Upturn unsubscribed user
$1.14/ day, billed weekly
Cancel anytime
(Ad-Free, Unlimited access)​
NO CREDIT CARD REQUIRED
VMD logo VMD
Upturn stock ratingUpturn stock rating
VMD logo

Viemed Healthcare Inc (VMD)

Upturn stock ratingUpturn stock rating
$6.89
Last Close (24-hour delay)
upturn advisory
PASS
  • BUY Advisory
  • SELL Advisory (Profit)​
  • SELL Advisory (Loss)​
  • Profit
  • Loss
  • Pass (Skip investing)
Upturn Stock infoUpturn Stock info Stock price based on last close
*as per simulation
(see disclosures)
Time period over
  • ALL
  • YEAR
  • MONTH
  • WEEK

Upturn Advisory Summary

08/14/2025: VMD (1-star) is currently NOT-A-BUY. Pass it for now.

Upturn Star Rating

rating

Not Recommended Performance

These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.

Number of Analysts

rating

3 Analysts rated it

Very few follow this stock; limited insights, higher-risk early investing.

1 Year Target Price $13

1 Year Target Price $13

Analysts Price Target For last 52 week
$13 Target price
52w Low $5.93
Current$6.89
52w High $9.81

Analysis of Past Performance

Type Stock
Historic Profit -4.88%
Avg. Invested days 37
Today’s Advisory PASS
Upturn Star Rating Upturn stock ratingUpturn stock rating
Upturn Advisory Performance Upturn Advisory Performance 2.0
Stock Returns Performance Upturn Returns Performance 1.0
Upturn Profits based on simulationUpturn Profits based on simulation Profits based on simulation
Upturn Profits based on simulationUpturn Profits based on simulation Last Close 08/14/2025

Key Highlights

Company Size Small-Cap Stock
Market Capitalization 267.23M USD
Price to earnings Ratio 20.26
1Y Target Price 13
Price to earnings Ratio 20.26
1Y Target Price 13
Volume (30-day avg) 3
Beta 1.34
52 Weeks Range 5.93 - 9.81
Updated Date 08/15/2025
52 Weeks Range 5.93 - 9.81
Updated Date 08/15/2025
Dividends yield (FY) -
Basic EPS (TTM) 0.34

Analyzing Revenue: Products, Geography and Growth

Revenue by Products

Product revenue - Year on Year

Earnings Date

Report Date 2025-08-06
When -
Estimate 0.085
Actual 0.08

Profitability

Profit Margin 5.8%
Operating Margin (TTM) 7.16%

Management Effectiveness

Return on Assets (TTM) 5.95%
Return on Equity (TTM) 10.87%

Valuation

Trailing PE 20.26
Forward PE 16.89
Enterprise Value 254107879
Price to Sales(TTM) 1.11
Enterprise Value 254107879
Price to Sales(TTM) 1.11
Enterprise Value to Revenue 1.05
Enterprise Value to EBITDA 5.82
Shares Outstanding 38785800
Shares Floating 31532046
Shares Outstanding 38785800
Shares Floating 31532046
Percent Insiders 13.08
Percent Institutions 62.04

ai summary icon Upturn AI SWOT

Viemed Healthcare Inc

stock logo

Company Overview

overview logo History and Background

Viemed Healthcare, Inc. was founded in 2006. It focuses on providing in-home durable medical equipment and respiratory therapy services.

business area logo Core Business Areas

  • Respiratory Therapy: Provides in-home respiratory therapy services, including ventilation, oxygen therapy, and related equipment and supplies.
  • Durable Medical Equipment (DME): Supplies a range of DME, such as wheelchairs, walkers, and hospital beds, to patients in their homes.

leadership logo Leadership and Structure

Casey Hoyt is the CEO. The company operates with a hierarchical structure typical of publicly traded corporations, with departments for operations, finance, sales, and marketing.

Top Products and Market Share

overview logo Key Offerings

  • Ventilators: Provides ventilators for patients with chronic respiratory conditions. Market share data is not readily available at the product level. Competitors include ResMed (RMD) and Philips (PHG).
  • Oxygen Therapy: Offers oxygen concentrators and related supplies. Market share data is not readily available at the product level. Competitors include AdaptHealth (AHCO) and Lincare (not publicly traded).
  • Non-invasive Ventilation(NIV): Offers NIV for patients in-home with various types of respiratory failure. Market share data is not readily available at the product level. Competitors include ResMed (RMD) and Philips (PHG).

Market Dynamics

industry overview logo Industry Overview

The home healthcare industry is growing due to an aging population, increasing prevalence of chronic diseases, and a shift towards cost-effective care settings. Increased demand and reimbursement changes can impact the market.

Positioning

Viemed focuses on high-acuity respiratory care at home, differentiating itself through specialized services and a focus on patient outcomes. They aim to reduce hospital readmissions.

Total Addressable Market (TAM)

The estimated TAM for the home medical equipment and respiratory therapy market is in the tens of billions of dollars annually. Viemed captures a small, but growing, portion of this TAM. Specific numbers change based on reports and definitions.

Upturn SWOT Analysis

Strengths

  • Specialized in-home respiratory care
  • Focus on patient outcomes and reducing hospital readmissions
  • Established relationships with physicians and hospitals
  • Strong growth in revenue and patient census

Weaknesses

  • Dependence on reimbursement rates and regulatory environment
  • Geographic concentration in certain regions
  • Potential for increased competition
  • Smaller size compared to larger competitors

Opportunities

  • Expanding into new geographic markets
  • Developing new respiratory therapy programs
  • Acquiring smaller competitors
  • Leveraging telehealth and remote monitoring technologies

Threats

  • Changes in Medicare and Medicaid reimbursement policies
  • Increased competition from larger home healthcare providers
  • Supply chain disruptions
  • Negative publicity or litigation related to billing practices

Competitors and Market Share

competitor logo Key Competitors

  • RMD
  • AHCO

Competitive Landscape

Viemed has an advantage in high-acuity respiratory care but is smaller than major players like ResMed and AdaptHealth. They face competition based on price, service quality, and geographic coverage.

Major Acquisitions

Sleep Management, LLC

  • Year: 2021
  • Acquisition Price (USD millions): 15.8
  • Strategic Rationale: Expanded geographic footprint and enhanced sleep disorder services.

Growth Trajectory and Initiatives

Historical Growth: Viemed has experienced significant revenue growth in recent years, driven by increasing demand for its services and strategic acquisitions.

Future Projections: Analyst estimates can be found on various financial websites. The estimates provide projections for revenue, earnings, and growth rates.

Recent Initiatives: Viemed has been focused on expanding its geographic footprint, investing in telehealth capabilities, and developing new respiratory therapy programs.

Summary

Viemed Healthcare is a growing company in the in-home respiratory care market, specializing in high-acuity services. They demonstrate significant revenue growth with strategic acquisitions. Viemed faces risks related to reimbursement policies and competition from larger companies. They should focus on expanding market share and managing costs effectively.

Peer Comparison

Sources and Disclaimers

Data Sources:

  • Company SEC Filings (10-K, 10-Q)
  • Company Website
  • Analyst Reports (Yahoo Finance, Google Finance)
  • Industry Reports

Disclaimers:

This analysis is for informational purposes only and should not be considered financial advice. Market share data is estimated and may vary based on source and definition. Financial data needs to be collected from sources such as SEC filings for the last 4 years (10k reports).

Upturn AI SummarizationUpturn AI Summarization AI Summarization is directionally correct and might not be accurate.

Upturn AI SummarizationUpturn AI Summarization Summarized information shown could be a few years old and not current.

Upturn AI SummarizationUpturn AI Summarization Fundamental Rating based on AI could be based on old data.

Upturn AI SummarizationUpturn AI Summarization AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.

About Viemed Healthcare Inc

Exchange NASDAQ
Headquaters Lafayette, LA, United States
IPO Launch date 2017-12-22
CEO & Director Mr. Casey Hoyt
Sector Healthcare
Industry Medical Devices
Full time employees 1258
Full time employees 1258

Viemed Healthcare, Inc., through its subsidiaries, provides home medical equipment (HME) and post-acute respiratory healthcare services in the United States. The company provides respiratory disease management solutions, including treatment of chronic obstructive pulmonary disease (COPD), which include non-invasive ventilation, percussion vests, and other therapies; and invasive and non-invasive ventilation and related equipment and supplies to patients suffering from COPD. It also sells and rents HME devices, such as non-invasive and invasive ventilators, positive airway pressure (PAP) machines, durable medical equipment, percussion vests, oxygen concentrators, and other medical equipment. In addition, the company provides neuromuscular care and oxygen therapy services; and sleep apnea management that provides sleep solutions and/or equipment, such as PAP, automatic continuous positive airway pressure, and bi-level positive airway pressure machines. Further, the company offers in home sleep apnea testing services, as well as healthcare staffing and recruitment services. Viemed Healthcare, Inc. was founded in 2006 and is headquartered in Lafayette, Louisiana.